Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Refining epigenetic prediction of chronological and biological age

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Epigenetic clocks can track both chronological age (cAge) and biological age (bAge). The latter is typically defined by physiological biomarkers and risk of adverse health outcomes, including all-cause mortality. As cohort sample sizes increase, estimates of cAge and bAge become more precise. Here, we aim to develop accurate epigenetic predictors of cAge and bAge, whilst improving our understanding of their epigenomic architecture.

          Methods

          First, we perform large-scale ( N = 18,413) epigenome-wide association studies (EWAS) of chronological age and all-cause mortality. Next, to create a cAge predictor, we use methylation data from 24,674 participants from the Generation Scotland study, the Lothian Birth Cohorts (LBC) of 1921 and 1936, and 8 other cohorts with publicly available data. In addition, we train a predictor of time to all-cause mortality as a proxy for bAge using the Generation Scotland cohort (1214 observed deaths). For this purpose, we use epigenetic surrogates (EpiScores) for 109 plasma proteins and the 8 component parts of GrimAge, one of the current best epigenetic predictors of survival. We test this bAge predictor in four external cohorts (LBC1921, LBC1936, the Framingham Heart Study and the Women’s Health Initiative study).

          Results

          Through the inclusion of linear and non-linear age-CpG associations from the EWAS, feature pre-selection in advance of elastic net regression, and a leave-one-cohort-out (LOCO) cross-validation framework, we obtain cAge prediction with a median absolute error equal to 2.3 years. Our bAge predictor was found to slightly outperform GrimAge in terms of the strength of its association to survival (HR GrimAge = 1.47 [1.40, 1.54] with p = 1.08 × 10 −52, and HR bAge = 1.52 [1.44, 1.59] with p = 2.20 × 10 −60). Finally, we introduce MethylBrowsR, an online tool to visualise epigenome-wide CpG-age associations.

          Conclusions

          The integration of multiple large datasets, EpiScores, non-linear DNAm effects, and new approaches to feature selection has facilitated improvements to the blood-based epigenetic prediction of biological and chronological age.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13073-023-01161-y.

          Related collections

          Most cited references80

          • Record: found
          • Abstract: not found
          • Article: not found

          Regularization and variable selection via the elastic net

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            DNA methylation age of human tissues and cell types

            Background It is not yet known whether DNA methylation levels can be used to accurately predict age across a broad spectrum of human tissues and cell types, nor whether the resulting age prediction is a biologically meaningful measure. Results I developed a multi-tissue predictor of age that allows one to estimate the DNA methylation age of most tissues and cell types. The predictor, which is freely available, was developed using 8,000 samples from 82 Illumina DNA methylation array datasets, encompassing 51 healthy tissues and cell types. I found that DNA methylation age has the following properties: first, it is close to zero for embryonic and induced pluripotent stem cells; second, it correlates with cell passage number; third, it gives rise to a highly heritable measure of age acceleration; and, fourth, it is applicable to chimpanzee tissues. Analysis of 6,000 cancer samples from 32 datasets showed that all of the considered 20 cancer types exhibit significant age acceleration, with an average of 36 years. Low age-acceleration of cancer tissue is associated with a high number of somatic mutations and TP53 mutations, while mutations in steroid receptors greatly accelerate DNA methylation age in breast cancer. Finally, I characterize the 353 CpG sites that together form an aging clock in terms of chromatin states and tissue variance. Conclusions I propose that DNA methylation age measures the cumulative effect of an epigenetic maintenance system. This novel epigenetic clock can be used to address a host of questions in developmental biology, cancer and aging research.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays.

              The recently released Infinium HumanMethylation450 array (the '450k' array) provides a high-throughput assay to quantify DNA methylation (DNAm) at ∼450 000 loci across a range of genomic features. Although less comprehensive than high-throughput sequencing-based techniques, this product is more cost-effective and promises to be the most widely used DNAm high-throughput measurement technology over the next several years. Here we describe a suite of computational tools that incorporate state-of-the-art statistical techniques for the analysis of DNAm data. The software is structured to easily adapt to future versions of the technology. We include methods for preprocessing, quality assessment and detection of differentially methylated regions from the kilobase to the megabase scale. We show how our software provides a powerful and flexible development platform for future methods. We also illustrate how our methods empower the technology to make discoveries previously thought to be possible only with sequencing-based methods. http://bioconductor.org/packages/release/bioc/html/minfi.html. khansen@jhsph.edu; rafa@jimmy.harvard.edu Supplementary data are available at Bioinformatics online.
                Bookmark

                Author and article information

                Contributors
                riccardo.marioni@ed.ac.uk
                Journal
                Genome Med
                Genome Med
                Genome Medicine
                BioMed Central (London )
                1756-994X
                28 February 2023
                28 February 2023
                2023
                : 15
                : 12
                Affiliations
                [1 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, , University of Edinburgh, ; Edinburgh, UK
                [2 ]GRID grid.19006.3e, ISNI 0000 0000 9632 6718, Department of Human Genetics, David Geffen School of Medicine, , University of California, ; Los Angeles, CA USA
                [3 ]Altos Labs, San Diego, USA
                [4 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Edinburgh Clinical Research Facility, , University of Edinburgh, ; Edinburgh, UK
                [5 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Department of Psychology, , Lothian Birth Cohorts, University of Edinburgh, ; Edinburgh, UK
                [6 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Medical Research Council Human Genetics Unit, Institute of Genetics and Cancer, , University of Edinburgh, ; Edinburgh, UK
                [7 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Centre for Clinical Brain Sciences, , University of Edinburgh, ; Edinburgh, UK
                [8 ]GRID grid.507332.0, ISNI 0000 0004 9548 940X, BHF Data Science Centre, Health Data Research UK, ; London, UK
                [9 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Edinburgh Medical School, , Usher Institute, University of Edinburgh, ; Edinburgh, UK
                [10 ]GRID grid.4305.2, ISNI 0000 0004 1936 7988, Division of Psychiatry, , University of Edinburgh, Royal Edinburgh Hospital, ; Edinburgh, UK
                [11 ]GRID grid.33565.36, ISNI 0000000404312247, Institute of Science and Technology Austria, ; Klosterneuburg, Austria
                [12 ]GRID grid.499548.d, ISNI 0000 0004 5903 3632, The Alan Turing Institute, ; London, UK
                Author information
                http://orcid.org/0000-0002-5848-5720
                Article
                1161
                10.1186/s13073-023-01161-y
                9976489
                36855161
                7e6006c2-2d13-4745-b366-dc99552619d9
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 8 September 2022
                : 6 February 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100010269, Wellcome Trust;
                Award ID: 108890/Z/15/Z
                Funded by: FundRef http://dx.doi.org/10.13039/100010269, Wellcome Trust;
                Award ID: 104036/Z/14/Z
                Funded by: FundRef http://dx.doi.org/10.13039/100010269, Wellcome Trust;
                Award ID: 108890/Z/15/Z
                Funded by: FundRef http://dx.doi.org/10.13039/100010269, Wellcome Trust;
                Award ID: 221890/Z/20/Z
                Funded by: Alzheimer's Society (GB)
                Award ID: AS-PG-19b-010
                Funded by: Alzheimer's Society (GB)
                Award ID: AS-PG-19b-010
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Funded by: FundRef http://dx.doi.org/10.13039/501100021847, Centro Svizzero di Calcolo Scientifico;
                Award ID: PCEGP3-181181
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Award ID: MC_UU_00007/10
                Categories
                Research
                Custom metadata
                © The Author(s) 2023

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article